GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...

In people with recently diagnosed type 2 diabetes and no prior cardiovascular disease, self-reported physical activity ...

With follow-up ranging from 1 to 11 years, use of GLP-1 agonists, such as semaglutide (Ozempic, Wegovy) and tirzepatide ...

Real world data that harnesses deidentified health records is a multi-billion-dollar industry. But what is the value of a ...

Influenza Pipeline Summary. DelveInsight’s Influenza Emerging Drugs report highlights innovative therapies advancing the ...

The pharmaceutical drug delivery market is entering a transformative phase, projected to grow from USD 1,949.4 billion in ...

Pharmaceutical technology exports have exceeded KRW 10 trillion this year, according to an Aug. 19 report based on Global ...

China’s biotechnology sector has established a bright future by focusing not on breakthrough cures and treatments but on ...

Developer Hadley Property Group has lodged a hybrid planning application to redevelop the flagship former GlaxoSmithKline headquarters in Brentford, West London. The ambitious scheme at 980 Great West ...

Investors are increasingly turning to ‘safer’ MNC pharma stocks with a domestic focus at a time when the Trump administration ...

The pneumococcal infection market is poised for steady growth, driven by a combination of high global disease burden, rising antimicrobial resistance, and expanded immunization initiatives. Analyst ...

The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).